Sinopharm
1099.HK
#1870
Rank
โ‚น734.65 B
Marketcap
โ‚น235.42
Share price
-0.23%
Change (1 day)
17.02%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2023 (TTM): โ‚น5.089 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น6.827 Trillion. In 2022 the company made a revenue of โ‚น6.827 Trillion a decrease over the revenue in the year 2021 that were of โ‚น6.973 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚น5.089 T-25.45%
2022 โ‚น6.827 T-2.1%
2021โ‚น6.973 T16.85%
2020โ‚น5.967 T14.95%
2019โ‚น5.191 T21.52%
2018โ‚น4.272 T5.93%
2017โ‚น4.033 T27.22%
2016โ‚น3.170 T5.37%
2015โ‚น3.008 T9.14%
2014โ‚น2.756 T17.22%
2013โ‚น2.351 T25.94%
2012โ‚น1.867 T34.61%
2011โ‚น1.387 T55.34%
2010โ‚น892.89 B35.79%
2009โ‚น657.56 B37.56%
2008โ‚น478.03 B31.43%
2007โ‚น363.72 B40.26%
2006โ‚น259.31 B